Connor, Clark & Lunn Investment Management (CC&L)’s CHELSEA THERAPEUTICS INT'L LTD CHTP Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio CHTP Stock Details CHTP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-13,400	Closed	-$82K	–	729
2014 Q1	$82K	Buy	+13,400	New	+$67.3K	﹤0.01%	658
2013 Q4	–	Sell	-48,522	Closed	-$149K	–	798
2013 Q3	$149K	Buy	+48,522	New	+$139K	﹤0.01%	471

Other funds holding CHTP

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.82% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s CHTP Position: Q2 2014 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of CHELSEA THERAPEUTICS INT'L LTD (CHTP) in Q2 2014, closing a stake of 13,400 shares — an estimated $82K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in CHTP in Q3 2013 and held it in 2 quarters. The position peaked at $149K in Q3 2013. 6 funds tracked by Wall St. Rank hold CHTP as of Q2 2014.

Connor, Clark & Lunn Investment Management (CC&L) reported no remaining CHELSEA THERAPEUTICS INT'L LTD position as of Q2 2014 after selling out during the quarter.
Connor, Clark & Lunn Investment Management (CC&L) sold 13,400 CHELSEA THERAPEUTICS INT'L LTD shares in Q2 2014, an estimated $82K.
Connor, Clark & Lunn Investment Management (CC&L) first reported a position in CHELSEA THERAPEUTICS INT'L LTD in Q3 2013 and held it in 2 quarters.
Connor, Clark & Lunn Investment Management (CC&L)'s CHELSEA THERAPEUTICS INT'L LTD position peaked at $149K in Q3 2013.
6 funds tracked by Wall St. Rank held CHELSEA THERAPEUTICS INT'L LTD as of Q2 2014.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2014, filed 14 Aug 2014.